发明名称 Pyrrolidin und Piperidin Derivate
摘要 The present invention relates to the use of pyrrolidine and piperidine derivatives of the general formulae <CHEM> wherein R<1> and R<2> are, independently from each other, hydrogen, lower alkoxy, hydroxy, halogen, -CONH2 or -C(O)O-lower alkyl; or taken together are -O-CH2-O-; R<3> and R<4> are, independently from each other, hydrogen, lower alkoxy, benzyloxy, halogen, hydroxy, -CONH2 or -SCH3; or taken together are -O-CH2-O-; R<5> is hydrogen or lower alkyl; X and Y are, independently from each other -CH(OH)-, -(CH2)n-, -C(O)- or -CH(lower alkoxy)-; and m, n and p are 1 or 2; and to their pharmaceutically acceptable addition salts for the treatment of diseases caused by overactivation of NMDA receptor subtypes.
申请公布号 DE69922858(T2) 申请公布日期 2006.04.13
申请号 DE1999622858T 申请日期 1999.02.02
申请人 F. HOFFMANN-LA ROCHE AG, BASEL 发明人 ALANINE, ALEXANDER;BUETTELMANN, BERND;HEITZ NEIDHART, MARIE-PAULE;PINARD, EMMANUEL;WYLER, RENE
分类号 A61K31/40;C07D211/22;A61K31/00;A61K31/4025;A61K31/42;A61K31/424;A61K31/435;A61K31/437;A61K31/443;A61K31/445;A61K31/4525;A61K31/505;A61K31/535;A61K31/5375;A61K31/5383;A61P25/00;A61P25/14;A61P25/16;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P43/00;C07D;C07D207/06;C07D207/08;C07D207/09;C07D211/32;C07D263/52;C07D265/34;C07D265/36;C07D405/06;C07D498/04 主分类号 A61K31/40
代理机构 代理人
主权项
地址